HP-TAT

N/A

Report date: 2025/01/26 19:19:51
NME

Base Information

Drug NameHP-TAT
Drug Alias Nameintegrin alpha-v/beta-3 modulator (NanoPharmaceuticals)HP-TAT
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIntegrin alpha-V/beta-3 modulators
TargetsIntegrin alpha-V/beta-3
Therapy Area/IndicationsMacular DegenerationDiabetic Retinopathy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNanoPharmaceuticals LLC
China Registration ClassN/A

Develop Information

Active CompaniesNanoPharmaceuticals LLC
Inactive CompaniesN/A
Active IndicationsMacular DegenerationDiabetic Retinopathy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A